FDAClass IIApril 29, 2020

Cefixime for Oral Suspension USP recall: Subpotent

Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States…

Why was Cefixime for Oral Suspension USP recalled?

Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: F800779, Expiry 4/2020

Product
Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States…
Recalling firm
Lupin Pharmaceuticals Inc.
Quantity
4,518 bottles
Distribution
Nationwide with the United States and Puerto Rico.
Recall date
April 29, 2020
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls